oric-944
oric pharmaceuticals pharmaceuticals
['oric-944']
this week we presented promising preclinical data highlighting oric-944, our potent and selective allosteric inhibitor of prc2, as well as our novel plk4 discovery program at #aacr2023. learn more about preclinical data presented here: 
Our name=our mission. Dedicated to improving patients’ lives using precision oncology to develop novel therapies aimed at key tumor dependencies. (Nasdaq: ORIC)